Table 2 Analgesics consumption, complications, and outcome data during the postoperative period
Parameters | Group CINB (n = 130) | Group SI (n = 86) | P |
|---|---|---|---|
Length of hospital stay, day | 17(15–22) | 16(14–20) | 0.026 |
Postoperative hospital stay, day | 8(7–10) | 8(7–10) | 0.033 |
Postoperative intubation time, h | 11.0(6.5–18.0) | 8.0(6.0–12.3) | 0.008 |
Length of ICU stay, h | 21.0(15.8–42.8) | 22.0(18.5–43.5) | 0.308 |
Tramadol consumption, mg | 0(0–100) | 100(0–225) | 0.0001 |
Tramadol requirement | 63(48%) | 61(71%) | 0.001 |
Pethidine consumption, mg | 0(0–25) | 25(0–50) | 0.0004 |
Pethidine requirement | 43(33%) | 48(56%) | 0.001 |
Maximal pain (VAS 0–10) | 5.00(3.00–5.00) | 6.00(4.75–6.00) |  < 0.0001 |
No. of max VAS ≤ 3a | 52(40%) | 17(20%) | 0.002 |
Dyspnea | 1(0.8%) | 1(1.2%) | 1.000 |
Somnolence Pruritus | 0(0%) / | 1(1.2%) / | 0.398 |
PONV | 21(16%) | 12(14%) | 0.704 |
Atelectasis | 4(3.1%) | 2(2.3%) | 1.000 |
Pulmonary exudation | 67(52%) | 49(57%) | 0.433 |
Pleural effusion | 59(45%) | 41(48%) | 0.741 |
Pneumothorax | 3(2.3%) | 5(5.8%) | 0.270 |